Surgical treatment of thyrotoxicosis in children and adolescents by Thompson, Norman W. et al.
Surgical Treatment of Thyrotoxicosis 
in Children and Adolescents 
By Norman W. Thompson, Ernest 1. Dunn, John E. Freitas, James C. Sisson, 
Arnold G. Coran, and Ronald H. Nishiyama 
l Forty-one children and adolescents 
had thyroidectomies for Grave’s disease 
during an 8 yr period. Twenty patients 
became euthyroid within a short period 
after treatment with antithyroid drugs 
and had operations with minimal ditrup- 
tion of their lives. Antithyroid drugs were 
administered to 20 patients for a longer 
period of time as a primary form of treat- 
ment for Grave’s disease. Complications 
resulting from drug toxicity, poor coopera- 
tion by patients, and persistent goiters 
were indications for thyroidectomier in 
this group. Permanent remissions, after 
prolonged antithyroid drug therapy, are 
rare in children. Because the treatment is 
associated with significant morbidity, this 
form of therapy is unacceptable in most 
cases. Iodine-131 was given to 30 children 
or adolescents for Grave’s disease during 
the same time period. Iodine-131 is pri- 
marily indicated for patients who are re- 
sistant or allergic to antithyroid drugs, 
I7 ORTY-FIVE CHILDREN, 13 yr 
who have serious systemic diseases, or 
who have had previous thyroid opemtions. 
Hypothyroidism is an inevitable result of 
effective “‘I treatment of Grave’s disey;; 
in children. Serious consequences from I 
therapy were not observed during the 
short period of follow-up. Subtotal thy- 
roidectomy continues to be the preferred 
primary treatment for most patients with 
Grave’s disease in childhood. Total thy- 
roidectomy may be indicated for patients 
in the first decade of life. Hypothyroidism, 
which is easily managed in this age group, 
is the price paid for the prevention of 
recurrent Grave’s disease. Early detection 
and treatment of hypothyroidism can be 
achieved only by a careful follow-up of all 
patients treated by less than total thyroid- 
ectomy for Grave’s disease. 
INDEX WORDS: Thyrotoxicosis; Grave’s 
disease. 
of age or younger, were treated for 
I’ thyrotoxicosis at the University of Michigan Medical Center during the 
period from 1945-1965. The results in this group were first reported in 1969.’ 
It was then concluded that subtotal thyroidectomy was the operation of choice 
for these patients because of the low morbidity, early remission and low in- 
cidence of hypothyroidism. 
This report updates our data by including 41 more children who were treated 
surgically during the past 8 yr, 1969-1976, and an additional 30 children treated 
with radioactive iodine (13’I). This review was done to reevaluate the role of 
subtotal thyroidectomy in the management of thyrotoxicosis in children and 
adolescents. 
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MATERIALS AND METHODS 
The clinical diagnosis of thyrotoxicosis was confirmed by determinations of serum tri- 
iodothyronine and serum thyroxine or protein-bound iodine in earlier cases. In a number of 
cases, scintiscans and 24 hr uptakes of 13’1 were obtained. Thyroidectomies were performed 
in 21 female and 20 male patients. The mean age was 13.3 yr, with a range of from 2-18 yr of 
age. Thirty-eight patients were white, and three black. Seven children were 10 yr of age or 
younger when the diagnosis of thyrotoxicosis was made and treatment begun. 
The most common symptoms were nervousness, irritability, weight loss, and failure in school. 
The most common physical findings were exophthalmos, systolic hypertension, tachycardia, and 
weight loss. In 38 patients, the thyroid gland was diffusely enlarged, ranging from two to six 
times the size of a normal gland. Two patients had prominent solitary nodules in enlarged 
glands. One patient had a multinodular gland. 
After the diagnosis of Grave’s disease had been established, all patients were made euthyroid 
with either propylthiouracil or methimazole. Most patients were given Lugol’s solution one to 
two weeks before the operation. However, during the last few years, propranolol was also given 
at the time antithyroid drug therapy was begun or for several weeks preoperatively. Iodine 
was omitted. There were 21 patients who had the operation at a time which was convenient for 
the family. This ranged from 6 wk to 6 mo after antithyroid drugs were given. 
Long term treatment with antithyroid drugs had been undertaken for 20 children. All of 
these patients were treated with the hope of avoiding an operation and treatment with radio- 
active iodine (Table 1). The time of treatment ranged from 3 mo to 3 yr. In seven patients, with 
and without goiters, operation was done to treat hyperthyroidism which recurred after a 2 yr 
course of treatment with propylthiouracil. In three, operations were done for cosmetic reasons, 
although the signs and symptoms of hiperthyroidism had been controlled. One operation was 
done because of concern about cancer when a scintiscan of the thyroid gland showed a solitary 
cold nodule. An 18 yr old male had a subtotal thyroidectomy done because of failure to control 
atrial fibrillation by drug therapy. While taking methimazole for 6 mo, a 16 yr old girl had 
three episodes of intrathyroidal hemorrhage which finally led to a thyroidectomy. A I2 yr old boy 
had emotional problems in school while taking propylthiouracil for one year and was advised to 
have a thyroidectomy. Two girls, 13 and 17 yr of age, who were on antithyroid drugs for a year, 
were chronically absent from school and were poor students. They had subtotal thyroidectomies. 
A 9 yr old girl was unable to maintain a regular drug schedule despite attempts to closely super- 
vise her treatment. A 16 yr old boy, begun on propylthiouracil, developed hostility toward his 
parents and friends and a bizarre pattern of behavior. Two patients had less impressive com- 
plications. One patient found it impossible to adhere to a regular drug schedule and the other 
child required numerous adjustments of the dosage of her drug for 3 yr. 
Thirty-four patients had bilateral subtotal thyroid lobectomies. A single patient had a total 
lobectomy on one side and a subtotal lobectomy on the contralateral side. Six patients had total 
thyroidectomies. When bilateral subtotal thyroidectomies were done, 95%-989;, of the thyroid 
gland was removed, and an estimated 1-2 g of thyroid tissue were left on both sides. The amount 
of thyroid tissue excised varied with the size and age of the patient and ranged from 30 g to 
more than 80 g. The histologic sections of all of the thyroid glands were reviewed. 
Table 1. Failures of Long-Term Antithyroid Drugs 
Indication for Thyroidectomy Number of Patients 
Recurrence of thyrotoxicosis 7 
Persistent large goiter 3 
Inability to maintain drug schedule 3 
Failing in school work 2 
Severe emotional problems 2 
Palpable solitary, “cold” nodule 1 
Failure to control atria1 fibrillation 1 
3 episodes of intrathyroidol hemorrhage 1 
Total 20 
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Table 2. Radioactive Iodine Therapy for Grave’s Disease 
Indications 
Systemic Disease 
asthma, Downs syndrome, 
ulcerative colitis, psychosis, 
nephrotic syndrome 
Failure to control with antithyroid drugs 
Severe antithyroid drug reaction 
Refused recommended thyroidectomy 
Recurrence of thyrotoxicosis after 
subtotal thyroidectomy 
Selected as definitive treatment 
after l-2 of antithyroid drugs yr 
after 2-8 mo antithyroid drugs 
Number of Patients Age 
5 9, 10, 16, 17, 18 yr 
4 3, 12, 12, 18yr 
6 6, 10, 13, 15, 16, 16yr 
3 14, 16, 18yr 
3 15, 17, 18 yr 
4 15, 16, 17, 18yr 
5 10, 14, 15, 18, 18yr 
Thirty children were treated with 13’1 during the 8 yr period 1969 through 1976 (Table 2). 
The presence of hyperthyroidism was established by standard clinical and laboratory criteria. The 
thyroid gland ranged from Ii to 15 times normal size. Grave’s ophthalmopathy. Classes II 
and I11 (ATA criteria) was present in 434,. The mean age at the time of initial 13’1 therapy was 
15.1 years with a range of 3-18 yr. Females predominated: 24 of 30 patients. Thyroidectomy 
was felt to be contraindicated in 21 patients (Table 2) while in the remaining 9. 13’1 was se- 
lected because of the physician’s or patient’s preferences. Calculated doses of 13’1 were 60- 
200 uCi/g of thyroid; the mean dose of single therapies was 9.9 mCi with a range of 3-50.9 
mCi for cumulative doses. Five patients required more than one dose of “‘I. 
RESULTS 
There were no significant intraoperative or early postoperative complica- 
tions. Indirect laryngoscopy detected neither transient nor permanent injury to 
the recurrent laryngeal nerves. Two patients developed temporary hypocal- 
cemia which responded to treatment with calcium and vitamin DZ. Only one 
patient developed recurrent hyperthyroidism, two years after the removal of 
959; of the thyroid gland. She was treated with radioactive iodine. 
Twenty-three patients have been followed for 2 or more yr and nine, for 4-5 
yr. Fourteen patients, including the six who had total thyroidectomies, were 
operated upon within the last 2 yr. 
Hypothyroidism, detected by examinations beginning at least three months 
after the operation and at yearly intervals, developed in 27 of 41 patients 
(664;), including those treated by total thyroidectomies. Treatment with thyroid 
hormone, for most patients was initiated within the first year after the opera- 
tion. Of the patients not receiving thyroid hormone, none have developed hypo- 
thyroidism after one year. The usual replacement dose of dessicated thyroid is 
120 mg per day. 
The histologic sections of all thyroid glands showed the effects of treatment 
with propylthiouracil and Lugol’s iodine. The glands were in all stages of in- 
volution. Some were nearly completely involuted and composed largely of 
follicles lined by a flat epithelium and well filled with colloid. Other were only 
partially involuted with a mixture of well-involuted areas with areas showing 
residual hyperplastic changes. The degree of lymphocytic infiltration of the 
thyroid gland was evaluated in each case but there was no correlation with the 
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eventual development of hypothyroidism. One case had the classic changes of 
Hashimoto’s disease with a marked degree of fibrosis and lymphocytic and 
plasmacytic infiltrates. There was extensive atrophy of follicular epithelium. 
The histologic changes were very suggestive of those found in the glands of pa- 
tients with spontaneous myxedema. 
One patient treated with i3’I has been lost to follow-up and two patients have 
not been followed for sufficient time to assess the effects of therapy. Of the 
remaining 27 patients, 22 (8 1.4%) had relief of their hyperthyroidism from the 
first dose of 13’1, while four required two doses, and one required three. Hyper- 
thyroidism subsided in a mean time of 5.2 mo, a minimum of 2 mo, and a maxi- 
mum of 18 mo. There has been no recurrence of hyperthyroidism to date. Pro- 
gressive ophthalmopathy was not seen, but proptosis persisted in some patients. 
Associated with the elimination of hyperthyroidism by a single dose of 13’1 was 
a prevalence of biochemical hypothyroidism of 51.8% (14/27) 6 months after 
treatment. At the time of this report, hypothyroidism has been found in 74% 
(20/27) over a mean follow-up period of 44.5 months. The high incidence of 
subsequent hypothyroidism appeared to be independent of the size of the initial 
treatment dose. 
DISCUSSION 
The controversy over the optimal treatment of Grave’s disease in children 
and adolescents has not been resolved. Subtotal thyroidectomy is commonly 
recommended, but advocates of long term antithyroid drugs or radioactive 
iodine claim comparable results.2-‘9 More recently, surgeons have advocated 
total thyroidectomy because it eliminates recurrences, and with prompt and 
conscientious administration of thyroid hormone the development of hypo- 
thyroidism is avoided.2C22 
Treatment with antithyroid drugs has the disadvantage of requiring close 
supervision during a long period of time. In our experience, it is difficult to 
maintain children on propylthiouracil or methimazole even when the patient 
and parents are cooperative. Furthermore, permanent remission, after one to 
two years of therapy, has been unusual in adolescents and rare in children. 
In both groups, goiters have persisted and have been problems for the patient 
and the parents. Another dilemma is the development of allergic or toxic reac- 
tions to antithyroid drugs. Such patients are then referred for surgical treat- 
ment while still toxic, either due to failure to control the disease or a relapse 
after withdrawal of the drugs. Safe preparation of these patients for an opera- 
tion is difficult. Iodine and or propranolol may’alleviate the symptoms, but the 
risk of developing thyroid storm after an operation is increased in such cases. 
Therefore, during the past decade, the majority of such patients have been 
treated with 13’I. Pediatrician and surgeons have agreed that this is the best 
form of therapy. 
How effective are antithyroid drugs in controlling thyrotoxicosis in children 
and how often does a permanent remission result from their long term use? In 
our experience, only 4 of 71 patients (5.6%) were resistant to treatment with 
either methimazole or propylthiouracil. Toxic and allergic reactions in six oc- 
curred after these patients were controlled well. The antithyroid drugs have 
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allowed patients to have thyroidectomies while in a euthyroid state. Their use 
has virtually eliminated the postoperative complication of thyroid storm. 
Earlier investigators optimistically predicted that the long term use of anti- 
thyroid drugs in most patients with Grave’s disease would result in permanent 
remissions. In 1953, Solomon found that 55% of adult patients with Grave’s 
disease remained in remission for 4 yr after a course of antithyroid drugs of 
6 mo to I yr.z4 However, in the next two decades, other investigators reported a 
decreasing frequency of remissions even when antithyroid drugs were given for 
two years. Hayles and Chaves-Carballo found only 4 of 16 patients less than 15 
yr of age to be in remission 2 yr after a long term course of antithyroid drugs.(’ 
Data from major series published since 1954 show that among 99 children who 
were treated with antithyroid drugs and followed up for at least 2 yr after com- 
pletion of therapy, only 27 were not hyperthyroid.‘* In general, these results 
are considered unacceptable. Wartofsky recently suggested that the low rates of 
remission may be caused by an increased dietary intake of iodine and seriously 
questioned the long term use of antithyroid drugs.23 In his series remissions 
after long term treatment occurred in only 11% of his patients; none of these 
were under 21 yr of age. In our previous report, 10 of 64 children (16%) had 
prolonged remissions, and none of them were under 10 yr of age.’ The con- 
clusion at that time, was that subtotal thyroidectomy should be done in the 
pediatric patient with Grave’s disease unless contraindicated because of other 
concurrent disease or uncontrolled thyrotoxicosis. Neverless, nearly 507; of pa- 
tients having thyroidectomies or “‘I in the present review had received anti- 
thyroid drugs for 8 mo or longer in the hope of inducing a permanent remis- 
sion. Only 21 patients became promptly euthyroid and had an operation. Three 
of the 20 patients on a prolonged course of antithyroid drugs had no difficulty 
controlling their thyrotoxicosis. However, their thyroid glands continued to 
enlarge and because of problems of pressure symptoms and for cosmetic rea- 
sons, elective thyroidectomies were done. Seventeen patients had unacceptable 
results with drug treatment. In contrast, there were no complications in the 21 
patients who were given antithyroid drugs immediately after the diagnosis of 
Grave’s disease was confirmed, became euthyroid and had thyroidectomies. 
The time required to achieve this ranged from 6 wk to 3 mo. 
Those who advocate 13’1 in the treatment of childhood thyrotoxicosis em- 
phasize the ease with which it may be given, the low cost and its safety.‘5-‘9 
Radioiodine therapy is an effective means of terminating the hyperthyroid state 
in children within a period of months. We have been reluctant, however, to 
utilize this form of therapy in children, except when alternative forms of treat- 
ment were unacceptable because of the theoretical risks associated with radio- 
active iodine, such as the development of leukemia, carcinoma of the thyroid 
gland, the insidious development of hypothyroidism, and induction of genetic 
changes. The magnitude of the risk, when 13’1 is used to treat Grave’s disease 
during childhood, is unknown.25 Although its use is restricted in many hos- 
pitals, there are several where radioiodine is the treatment of choice for Grave’s 
disease in children and some data is being accumulated. None of the 291 pa- 
tients reported in the English literature as having received radioiodine for 
hyperthyroidism when aged 18 or younger have developed leukemia or in- 
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fertility nor have their progeny exhibited more congenital abnormalities than 
expected by chance.” Thyroid carcinoma was discovered in two children whose 
hyperthyroidism was barely controlled by small doses of 13’I. One of these de- 
veloped thyroid carcinoma within 27 mo of 13’1 therapy, which suggests that 
the carcinoma was already present at the time of radioiodine therapy.*‘j The 
other child received three small doses of 13’ I over a 4 yr period and then, 4 yr 
later, underwent a subtotal thyroidectomy for recurrent nodular goiter.27 Mul- 
tiple benign adenomas and one invasive “adenoma” of unknown size were 
found. The later child’s cancer may have been prevented by destroying more 
thyroid gland with larger doses of 13’I. The absence of cancer in other children 
treated with radioiodine may be attributable to the use of larger doses of 13’1 
which prevent thyroid cell replication. Further observation will be necessary 
to more firmly establish the safety of 13’1 therapy in children. In our hospital, 
the policy is to give 13’1 to patients 18 yr of age or younger only when other 
modes of treatment are contraindicated. We were surprised to find that 30 
children and adolescents had been treated with 1311 during 8 yr period covered 
by this review. Analysis of those cases shows that five had serious systemic dis- 
eases. Each patient had a protracted trial of antithyroid drugs with unsatis- 
factory results before 13’1 was given. Ten patients were still toxic after a pro- 
tracted period of treatment with antithyroid drugs. Four were never fully 
controlled by increasing doses of either methimazole or propylthiouracil, and 
six developed allergic or toxic reactions to the drugs. These patients had been 
euthyroid from several months to 3 yr. In retrospect, each of these patients 
could have had a thyroidectomy when they were euthyroid. Three patients 
with recurrent thyrotoxicosis after subtotal thyroidectomies were treated with 
13’I. Two of these patients had operations elsewhere and were referred for treat- 
ment with 13’1 after antithyroid drugs failed. The reluctance of three patients 
to have thyroidectomies resulted in the giving of 13’I. Nine patients were given 
13’1 after treatment with antithyroid drugs for 2 mo to 2 yr. These patients, 
who were lo-18 yr of age, had no apparent contraindications for operations. 
Hypothyroidism has been detected in 74% of the 27 patients treated with 
13’1 and followed for sufficient time to assess the effects of therapy. It is antici- 
pated that a decrease in dose would yield a lower prevalence of hypothyroidism 
after 6 mo, at the expense of persistent hyperthyroidism in many of the chil- 
dren. Only 81% of these patients were relieved of their hyperthyroidism with 
one dose of 13’I. The true incidence of permanent hypothyroidism is possibly 
less than 74%. However, in order to prevent physical growth retardation, re- 
placement therapy was initiated as soon as biochemical evidence of hypo- 
thyroidism occurred. We prefer to continue hormone therapy in all such pa- 
tients either as essential replacement or as therapy to prevent regrowth of goiter 
from residual tissue. The development of hypothyroidism should be anticipated 
in virtually all children who receive sufficient 13’1 to relieve thyrotoxicosis. 
We still believe that until a larger group of children are followed for a longer 
period of time, the use of 13’1 in children should be restricted to patients con- 
sidered unsuitable for other forms of treatment. 
The need for prompt and effective treatment of the thyrotoxicosis in the 
pediatric age group is obvious. These patients are in the midst of their physical 
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and emotional development. It is imperative that they be euthyroid during their 
years of growth and development. From our review, it is apparent that poorly 
treated thyrotoxicosis affected the learning ability and personality of these pa- 
tients, Prolonged treatment with antithyroid drugs is unacceptable for children 
unless they can be easily controlled and maintained on the drugs without 
constant supervision. Surgical treatment permanently restored these children to 
a euthyroid state with minimal disruption of their lives. Subtotal thyroidectomy 
is the preferred operation, providing it is done with no mortality and minimal 
morbidity. 
One patient out of 40 (2.50,;) developed recurrent hyperthyroidism after a pri- 
mary thyroidectomy. This occurred 2 yr after a standard subtotal thyroidec- 
tomy with no more than two or three grams of thyroid tissue left. This 9 yr old 
girl was treated with 13’I. A second patient had a subtotal thyroidectomy the 
year before the period of review, at 2 yr of age. Although only one gram of 
thyroid remnant was left on each side, rapid regeneration occurred, and a goiter 
was again palpable, At his second operation, 40 g of thyroid tissue was re- 
moved, and a total thyroidectomy was performed. This patient was the only 
child to have a recurrence in the group of 45 patients previously reported. We 
agree that treatment of recurrences after thyroidectomy should be with 13’1 
because of the high rate of complications reported with secondary thyroidec- 
tomies.‘4,28129.30 This patient’s age and the large goiter were the factors considered 
in doing a carefully performed total thyroidectomy. These are the only two 
children with recurrent thyrotoxicosis (2.3yb) after thyroidectomy during the 
past 30 yr among 85 patients. During the period of this review, our surgical 
philosophy has been to err toward removing too much rather than too little 
thyroid tissue to decrease the possibility of recurrent hyperthyroidism, a much 
more difficult problem to treat than hypothyroidism. A larger thyroid remnant 
results in a greater number of euthyroid patients but also increases the inci- 
dence of recurrent disease. When remnants are greater than 4 g, the incidence 
of recurrence may be as high as 4P;.9V’2,‘4,3’-35 The evidence shows that the two 
traditional goals of subtotal thyroidectomy for Grave’s disease, permanent cure 
and prevention of hypothyroidism, are mutually exclusive.’ We agree with Wes- 
ley and his colleagues who believe that the primary goal of the operation must 
be to remove enough thyroid tissue to insure that the patient will not continue 
to have hyperthyroidism. The surgeon should not be influenced by the pos- 
sibility of postoperative hypothyroidism.14 
Altman has suggested that total thyroidectomy may be an alternative pro- 
cedure in selected pediatric cases.20 In advocating total thyroidectomy, he em- 
phasizes that Grave’s disease is not “cured” by subtotal removal of the thyroid 
gland. The remnant is still subject to the stimulation that existed before the 
operation. He states that determination of the size of the remnant is an impre- 
cise and arbitrary decision in each case. Our experience confirms Altman’s 
observations in that two recurrences were in patients after a standard subtotal 
thyroidectomy when remnants of thyroid tissue estimated to be less than 4 g 
were left. The risk of rapid regeneration of thyroid remnants is greatest in pa- 
tients less than 10 yr of age. For this reason, we now consider total or near-total 
thyroidectomies in such patients. Perzik, on the other hand, recommends that 
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total thyroidectomy be done in all patients with Grave’s disease.21922 There were 
no deaths, no recurrences, no permanent recurrent laryngeal nerve injuries and 
only one patient, in his series of 326 patients, developed permanent hypo- 
parathyroidism. None of his patients developed or had progression of existing 
ophthalmopathy. The operations also eliminated occult or microscopic cancers 
which were found in 7% of his patients. All patients received exogenous thyroid 
hormone permanently, a procedure that does not differ from that used after 
many subtotal thyroidectomies. 
We believe that total thyroidectomy must be performed with no more mor- 
bidity than would occur after a subtotal or near-total thyroidectomy, if it is to 
be done to eliminate all recurrences of Grave’s disease.36 This goal is unlikely 
to be achieved by most surgeons unless they are very experienced and skillful 
in performing thyroid operations. We believe that recurrence is unlikely to oc- 
cur in patients over 15 yr of age following a subtotal thyroidectomy leaving a 
small remnant (2-4 g). Many of these patients will not require replacement with 
thyroid hormone. Because of the good results in this age group after subtotal 
thyroidectomy, we do not feel that total thyroidectomy is routinely justified. 
Hypothyroidism, in our group of patients, developed during the first year after 
operation. This observation agrees with that of Olsen and colleagues who found 
that 88% of patients who became hypothyroid after subtotal thyroidectomies 
were diagnosed within the first 6 mo.” The high incidence of hypothyroidism 
after subtotal thyroidectomy (60%) is attributed to the small remnant of thyroid 
tissue left and the careful follow-up examinations specifically designed to detect 
mild hypothyroidism. This high incidence markedly contrasts with the 5% re- 
ported in our patients by Tank and associates in 1969.’ In a partial follow-up 
of that group, however, additional patients have been found to be hypothyroid. 
A clinical diagnosis of mild hypothyroidism is difficult to establish in the 
pediatric patient. These patients often appear normal. In 1968, determinations 
of serum levels of T,, T,, and TSH were not used, and the criteria for the di- 
agnosis of hypothyroidism, used in the present study, were not available. A 
careful follow-up of these patients is important. The incipient development of 
hypothyroidism during a critical period of growth and development must be 
prevented. We have had no difficulty in treating hypothyroidism in the pediatric 
patient and do not consider its occurrence as a factor in our selection of treat- 
ment for Grave’s disease. 
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Discussion 
J. Wei/zman (Los Angeles): In the early part of this year we completed a paper dealing with 43 
patients who had subtotal thyroidectomy for thyrotoxicosis. Our results were the same as the 
series presented by Dr. Thompson. including a 65”,, incidence of hypothyroidism. Motivated by 
the hope of convincing other pediatric endocrinologists to believe, as the endocrinologists at 
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Children’s Hospital in Los Angeles believe, that subtotal thyroidectomy is the best treatment for 
hyperthyroidism in children, we submitted our manuscript to two pediatric journals. The follow- 
ing are some of the comments we received from the reviewers: “The main difference between the 
conclusions of these authors, including this reviewer, is the acceptability of 65”,, hypothyroidism 
as a complication. Committing a child to 50-70 yr of thyroid replacement should not be 
taken SO lightly. The problems of compliance with thyroid medication over a lifetime are not 
insignificant. Surgeons always minimize this at the same time that they maximize compliance 
problems of antithyroid medication.” In response to our stating that we believe thyroidectomy 
is the best form of treatment for hyperthyroidism. one reviewer stated. “Some of the religious 
fervor for surgery should be toned down.” Time does not allow me to repeat some of the other 
negative comments we received but we tinally gave up; our paper is to appear in a leading sur- 
gery journal in a few months. A study of adults successfully treated medically has shown that 
50”,, of them eventually become hypothyroid. I am afraid that many pediatric endocrinologists 
will not be convinced regarding thyroidectomy until it can be shown that many of the children 
who are successfully managed medically will become hypothyroid in the future. 
A. de Lorimer (Los Angeles]: I hope that Dr. Weitzman’s editorial quotes appear in that 200 
word discussion limit of the paper. There is no question that progressive hypothyroidism develops 
many years after radioiodine therapy. The longer one follows the series, the greater the incidence 
of hypothyroidism. It’ll probably be equivalent to that of surgical resection. 
J. Burringion (Chicago): How many surgeons here routinely begin thyroid replacement for all 
children after partial thyroidectomy? The “dos” have it two to one. It is very appealing to start 
all of the children on replacement right away although the family may wonder. “why have the 
operation if they have to take pills anyway’?” They might also miss a few days. notice no ap- 
parent ill effects and then not resume therapy. 
J. Ternherg (St. Louis/: It seems that more pediatric endocrinologists are agreeing with the 
Michigan and California groups. A member of our endocrine division has just reviewed the last 
60 cases of hyperthyroidism treated here. The conclusions were similar. that is: (I) an unaccept- 
ably high incidence of complications results from the use of antithyroid drugs, and (2) surgical 
treatment gives good results. They aiso agree that the necessity of taking thyroid medication fol- 
lowing thyroidectomy is innocuous, and should not be considered an unreasonable trade for the 
cure of hyperthyroidism. Indeed, in most cases. we start thyroid medication at the tirst follow-up 
visit. 1 would suggest that more positive results might come from publication by the pediatric 
endocrinologists rather than the pediatric surgeons. possibly as a collaborative effort by several 
institutions. 
N. Thompson (ClosingJ; I believe it is very important that we strive to have good results and 
avoid complications in order to maintain our position in the management of childhood thyro- 
toxicosis. Hypothyroidism occurs more frequently than we recognized in the past and cannot be 
avoided if recurrence is to be prevented. It should be emphasized that it can be detected during 
the first postoperative year and is as easily managed in children as it is in adults. Hypothyroidism 
of course, is frequent after 13’1 administration and was detected in 50”,, of our patients within 
6 mo and in 74”,, when the follow-up study was done at an average of 44 tn;, after therapy. We 
believe that if Grave’s disease in children is treated successfully with I. hypothyroidism 
will ultimately result in nearly all cases. Unlike hypothyroidism following thyroidectomy. which 
always occurred within the lirst year. ‘3’1-induced hypothyroidism may develop insidiously. 
years later, and go unrecognized. 
In regards to total thyroidectomy. I would emphasize that I would be very reluctant to advo- 
cate doing this in young children unless done by surgeons highly experienced in the procedure as 
the potential for complications is greater, Particular emphasis should be made in future reports 
about the incidence of recurrence in patients under IO yr of age in order that we might really 
know whether total thyroidectomy should be considered the procedure of choice in that age group. 
The available data is insufficient to support a tirm recommendation at this time. 
